biote Corp.
General ticker "BTMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $130.4M (TTM average)
biote Corp. does not follow the US Stock Market performance with the rate: -3.2%.
Estimated limits based on current volatility of 2.3%: low 2.53$, high 2.65$
Factors to consider:
- Total employees count: 217 (+11.9%) as of 2024
- US accounted for 97.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Rapid growth strain, Strategic risks and growth management, Regulatory and compliance, Geopolitical risks, Labor/talent shortage/retention
- Current price 43.9% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.58$, 7.98$]
- 2025-12-31 to 2026-12-31 estimated range: [4.86$, 8.43$]
Financial Metrics affecting the BTMD estimates:
- Positive: with PPE of 7.5 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 16.03
- Positive: Operating cash flow per share per price, % of 21.99 > 13.24
- Negative: Shareholder equity ratio, % of -86.56 <= 18.93
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of 0.04
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 0 < Industry operating cash flow per share per price (median), % of 3.25
- Negative: Investing cash flow per share per price, % of -9.14 <= -4.48
Short-term BTMD quotes
Long-term BTMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $164.96MM | $185.36MM | $197.19MM |
| Operating Expenses | $225.68MM | $156.70MM | $165.58MM |
| Operating Income | $-60.72MM | $28.66MM | $31.61MM |
| Non-Operating Income | $62.43MM | $-28.78MM | $-30.59MM |
| Interest Expense | $4.05MM | $6.36MM | $11.00MM |
| Income(Loss) | $1.71MM | $-0.12MM | $1.02MM |
| Taxes | $0.39MM | $2.68MM | $0.97MM |
| Profit(Loss)* | $-0.97MM | $3.32MM | $3.16MM |
| Stockholders Equity | $-44.46MM | $-29.40MM | $-105.93MM |
| Assets | $111.64MM | $155.29MM | $122.37MM |
| Operating Cash Flow | $-9.16MM | $26.88MM | $45.24MM |
| Capital expenditure | $1.84MM | $2.71MM | $6.43MM |
| Investing Cash Flow | $-1.84MM | $-2.71MM | $-18.80MM |
| Financing Cash Flow | $63.46MM | $-14.38MM | $-76.08MM |
| Earnings Per Share** | $-0.12 | $0.13 | $0.09 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.